Creo Medical Share Discussion Threads

[someuwin] 29/12/2023 10:18

Regarding robotic surgery CREO say..."We've got multiple partnership opportunities that we're looking at". This is excellent news as it's the robotic side of things which offers the real moonshot possibilities here imo. Remember that they already have partnership deals progressing with CMR Surgical and Intuitive Surgical Inc. (Nasdaq:ISRG - valuation $100bn)

We also know there are another 125 companies developing surgical robotics all of who will benefit from CREO tech.

[someuwin] 29/12/2023 10:14

Almost all bowel cancers start with lesions.

These lesions can now be cut out at the same time as doing an exploratory endoscopy using CREO's speedboat products.

i.e. a simple painless procedure over in an hour or so verses full scale surgical operation with several days in hospital recuperating.

Safer, better outcome for the patients. Much more efficient, quicker and cheaper for the NHS.

And that's just one of the many and growing uses for CREO devices.

[master investor] 29/12/2023 09:16

In March of this year the directors put 2.1 million pounds of their own money into CREO.

[wan] 29/12/2023 09:12

Parvez...Thanks for the Intuitive heads-up. Yes, the agreement with Intuitive adds to likelihood of strategic corporate action, and I note that that agreement includes a number of milestone payments to be made to Creo.

[master investor] 29/12/2023 09:00

Intuitive £93Billion market cap CREO £154million market cap

[parvez] 29/12/2023 08:59

Thanks, Parob! 35-45min mark on the video - very very interesting!

[parob] 29/12/2023 08:45

Yep, for any newbies looking in, it's worth watching this video from #TwinPetesInvesting - #CREO mentioned from 35 mins in.hTTps://www.youtube.com/watch?v=vvvHAjV2ywQ&t=3610s&pp=2AGaHJACAQ%3D%3DDiscussion that Intuitive who CREO have a multi-year agreement with could be a potential acquirer of CREO. hTTps://creomedical.com/latest_news/collaboration-agreement-with-intuitive/

[parvez] 29/12/2023 08:43

wan, thanks for sharing #348/351. Creo announced an small agreement with Intuative in May 2022 - they are a Robotic Assisted Medical company valued at apprx $85Bn I believe.



Wonder if there are further conversations with HOYA or Intuative taking place in view of recent FDA approvals...

[wan] 29/12/2023 08:43

And just to add to my post above, which I appreciate most long term holders are already aware of -

HOYA Group PENTAX Medical were a Strategic investor in CREO at the time of their IPO, and CREO Chief Commercial Officer, David Woods, was previously President and CEO of PENTAX Americas and M&A Director of Hoya Corporation.

[donald pond] 29/12/2023 08:42

Very flattering! If I were a major medtech company CREO is exactly at my buy point. Tech now proven, starting to launch, largely derisked and a global market to move into. Should be a pipeline of positive news from here and should do well.

[parob] 29/12/2023 08:26

Some of the bigger investor accounts on Twitter seem to be noticing CREO now.Donald PondhTTps://x.com/donaldpond6/status/1740646345524850824?s=46&t=_ybVnpe01AP_F1Pw0JqKTg#CREO moved up yesterday and looks an interesting company. Great medical tech, cashed up, huge market, lots of short term catalysts to full a big rerating imo.----All helps to bring wider attention to the stock.Many break out traders will be on to the stock now too following the break and close above 40p yesterday.

[wan] 29/12/2023 07:33

Creo has been on my radar for a 'very long' time, with my first investment back in the Autumn.

My take fwiw, is that with several important catalysts having been announced, there is a strong possibility of a deeper agreement and strategic alliance with a global player. Perhaps similar to HOYA Corporation (Pentax Medical) arrangement that provided a long-term multi-year platform for growth and has culminated in the recent acquisition of WASSENBURG Medical B.V on November 24, 2023 -

HOYA Corporation acquires the remaining stake of WASSENBURG Medical B.V.
November 24, 2023

Tokyo, Japan – 22nd November 2023 HOYA Corporation (HOYA) today acquired the remaining 49% of the shares of WASSENBURG Medical B.V (WASSENBURG), becoming the sole shareholder of the Dutchbased medical reprocessing company. WASSENBURG Medical is a global manufacturer of a complete range of systems, consumables and services covering all aspects of the endoscope reprocessing cycle. Completing this transaction will provide for further innovation in reprocessing of endoscopes solutions by combining the engineering power of WASSENBURG Medical and the flexible endoscopy division PENTAX Medical. “The strategic alliance formed between HOYA and WASSENBURG has provided for a strong platform of growth since 2013. WASSENBURG has more than doubled its turnover and opened additional direct affiliates in Europe and most recently in the United States, providing a platform for strong further growth. We are also delighted that Arno and Ronald Wassenburg, the Presidents of WASSENBURG, have agreed to continue leading WASSENBURG Medical in close cooperation with the PENTAX Medical team and other HOYA MedTech & Life Science divisions.” said Eiichiro IKEDA CEO of HOYA Corporation.

Full release -

[master investor] 28/12/2023 16:38

What a beautiful daily candle. This is the breakout of the ascending triangle with volume. Strong price action.

[cyberbub] 28/12/2023 16:37

Finished at day's high so potentially more to come tomorrow and next week?

[parob] 28/12/2023 15:44

Yes these were two great pieces of news in the last few months:Speedboat UltraSlim: EU launch accelerated by 18 months (25/10/23)ANDSpeedboat(R) UltraSlim: US FDA Clearance (1/11/23)Market didn't react much at the time, but is reacting now.

[nimbo10] 28/12/2023 14:56

Speedboat being used world wide not just EU/USA. Ramp up is going to be ahead of consensus. May get validation on how they are doing in trading update expected in Jan.

Tweeted News on 21stDec
"Following our EMEA and USA milestones, this week Speedboat UltraSlim was used for the first time in Latin America with Dr Michel Kahaleh, Dr Juan Alcivar and Dr Eduardo Albeniz performing #POEM & #FPOEM procedures at #IECED Hospital, Ecuador"

[sinzu] 28/12/2023 14:26

In the Final results for the 12 months ended 31 December 2022, reported 26/04/2023

"The fund raise of GBP33.7m (before expenses) in Q1 2023 provides us with the platform to achieve positive underlying EBITDA by 2025."


Since then, the following momentum accelerators have hastened the path towards profitability

- Speedboat UltraSlim:EU launch accelerated by 18 months, reported 25/10/2023

- Speedboat(R) UltraSlim: US FDA Clearance, reported 01/11/2023


"Together with the recent news of the accelerated regulatory pathway in the EU, we look forward to patients, clinicians and healthcare providers being able to benefit from the widespread commercialisation of Speedboat UltraSlim in both Europe and the US in 2024 and beyond."


"Knowing the potential that having a device that is compatible with all major endoscopes brings, we are energised to get the device into the hands of clinicans to allow them to treat their patients, for more indications and improve lives. With significant demand for this product already indicated from existing and potential Speedboat users , we will continue our early market release ahead of the full market launch in early 2024."

[master investor] 28/12/2023 13:30

I don't think that is unrealistic. Repeat orders and demand across the globe.

[cyberbub] 28/12/2023 13:24

They will have to more than 10x their Speedboat revenues in 2024 compared to 2023 IMO, to start approaching breakeven in 2025. As mentioned this is by no means impossible starting from a low base, but it's not easy.

[someuwin] 28/12/2023 13:16

I'll be surprised if CREO hasn't been bought out by this time next year.

[cyberbub] 28/12/2023 13:14

Is someone in the know about a possible positive TU in early Jan?The company is still losing lots of money, and will need a proper hockey stick in Speedboat revenues during 2024 to be able to reach breakeven in 2025 as they've forecast. Not impossible but a big ask IMO.But there is always the possibility that Intuitive will just decide to step in before that point and buy out the company for 100p + just to get their hands on the very valuable IP...

[master investor] 28/12/2023 11:53

No major resistance until 100p once we break 40p. Chart looks very good ?

[parob] 28/12/2023 11:11

Yep we have traded in the 30-40p range for over 6 months! So a break above 40p sees a pretty significant move imo.Really like the look of the chart.

[master investor] 28/12/2023 09:46

Looking strong. Break and close above 40p and this will really move.

[parob] 28/12/2023 09:14

Still a chance to go through 40p before the year is out.